Methyl 3-methyl-5-(4-methylphenyl)-1,2-oxazole-4-carboxylate

Catalog No. :
ACTJOO083
CAS No. :
1208081-29-1
Molecular Formula :
C13H13NO3
Molecular Weight :
231.25

IUPAC Name:methyl 3-methyl-5-(p-tolyl)isoxazole-4-carboxylate

Methyl 3-methyl-5-(4-methylphenyl)-1,2-oxazole-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$72.00Login to see priceInquiryInquiry
5g95%$306.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-methyl-5-(4-methylphenyl)-1,2-oxazole-4-carboxylate
IUPAC Namemethyl 3-methyl-5-(p-tolyl)isoxazole-4-carboxylate
MDL No.MFCD15142851
Molecular FormulaC13H13NO3
Molecular Weight231.25
SMILESO=C(C1=C(C2=CC=C(C)C=C2)ON=C1C)OC
InChI KeyWPYTZLQBFQUQSK-UHFFFAOYSA-N
Synonym3-Methyl-5-p-tolyl-isoxazole-4-carboxylic acid methyl ester;Methyl 3-methyl-5-(4-methylphenyl)-1,2-oxazole-4-carboxylate;Methyl 3-methyl-5-(p-tolyl)isoxazole-4-carboxylate;4-Isoxazolecarboxylic acid, 3-methyl-5-(4-methylphenyl)-, methyl ester
CAS No.1208081-29-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTJOO083 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYXCW831 route compound structure diagram
    ACYXCW8315720-05-8 In Stock
  4. Then
  5. ACTJOO083 route product structure diagram
    ACTJOO0831208081-29-1
Inquiry

2. ACTJOO083 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTJOO083 route product structure diagram
    ACTJOO0831208081-29-1
Inquiry

Comments (0)